TrialInternational journal of hematology2024
Long-term safety profile of sutimlimab in adult Japanese patients with cold agglutinin disease.
Yoshitaka Miyakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it